These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3171876)

  • 1. An alternative two stage method via the EM-algorithm for the estimation of population pharmacokinetic parameters.
    Amisaki T; Tatsuhara T
    J Pharmacobiodyn; 1988 May; 11(5):335-48. PubMed ID: 3171876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREME.
    Yates JW
    Comput Methods Programs Biomed; 2009 Oct; 96(1):49-62. PubMed ID: 19410328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics.
    Mentré F; Gomeni R
    J Biopharm Stat; 1995 Jul; 5(2):141-58. PubMed ID: 7581424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estimation of population pharmacokinetic parameters using an EM algorithm.
    Aarons L
    Comput Methods Programs Biomed; 1993 Sep; 41(1):9-16. PubMed ID: 8275683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of different population pharmacokinetic algorithms.
    Colucci P; Grenier J; Yue CS; Turgeon J; Ducharme MP
    Ther Drug Monit; 2011 Oct; 33(5):583-91. PubMed ID: 21912327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.
    Bach T; An G
    J Pharmacokinet Pharmacodyn; 2021 Aug; 48(4):581-595. PubMed ID: 33884580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.
    Savic RM; Mentré F; Lavielle M
    AAPS J; 2011 Mar; 13(1):44-53. PubMed ID: 21063925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.
    Steimer JL; Mallet A; Golmard JL; Boisvieux JF
    Drug Metab Rev; 1984; 15(1-2):265-92. PubMed ID: 6745083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.
    Liu X; Wang Y
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):359-70. PubMed ID: 27215925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM.
    Vermes A; Math t RA; van der Sijs IH; Dankert J; Guchelaar HJ
    Ther Drug Monit; 2000 Dec; 22(6):676-87. PubMed ID: 11128235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
    Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
    BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes.
    Urien S
    Pharm Res; 1995 Aug; 12(8):1225-30. PubMed ID: 7494838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.
    Bauer RJ; Guzy S; Ng C
    AAPS J; 2007 Mar; 9(1):E60-83. PubMed ID: 17408237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologies.
    Grasela TH; Antal EJ; Townsend RJ; Smith RB
    Clin Pharmacol Ther; 1986 Jun; 39(6):605-12. PubMed ID: 3709024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A row-action alternative to the EM algorithm for maximizing likelihood in emission tomography.
    Browne J; de Pierro AB
    IEEE Trans Med Imaging; 1996; 15(5):687-99. PubMed ID: 18215950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel.
    Dansirikul C; Choi M; Duffull SB
    Comput Biol Med; 2005 Jun; 35(5):389-403. PubMed ID: 15767115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.